MedTrace Logo

Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions

NCT04267419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-02-13

No results posted yet for this study

Summary

investigating the level of malondialdehyde (MDA) \& nitric oxide (NO) in saliva in oral premalignant and malignant lesions in order to determine their diagnostic value for the malignant and potentially malignant lesions.

Conditions

  • Oral Lichen Planus
  • Oral Cancer
  • Leukoplakia
  • Oral Keratoses

Interventions

DIAGNOSTIC_TEST

salivary biomarker

MDA and NO as salivary biomarkers

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • weam Elbattawy, Phd · Cairo University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2019-12-15
Completion
2019-12-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267419 on ClinicalTrials.gov